Alnylam Pharmaceuticals, Inc. Share Price
Equities
ALNY
US02043Q1076
Biotechnology & Medical Research
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
149.4 USD | +1.33% | -2.23% | -22.68% |
Sales 2024 * | 1.87B 148B | Sales 2025 * | 2.26B 178B | Capitalization | 18.64B 1,471B |
---|---|---|---|---|---|
Net income 2024 * | -451M -35.59B | Net income 2025 * | -257M -20.28B | EV / Sales 2024 * | 9.29 x |
Net cash position 2024 * | 1.26B 99.63B | Net cash position 2025 * | 475M 37.47B | EV / Sales 2025 * | 8.04 x |
P/E ratio 2024 * |
-41.7
x | P/E ratio 2025 * |
-79.2
x | Employees | 2,100 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.59% |
Latest transcript on Alnylam Pharmaceuticals, Inc.
1 day | +1.17% | ||
1 week | -2.23% | ||
Current month | +2.81% | ||
1 month | +0.87% | ||
3 months | +0.68% | ||
6 months | -12.41% | ||
Current year | -22.68% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 61 | 18/09/16 | |
Jeffrey Poulton
DFI | Director of Finance/CFO | 56 | 12/08/19 |
Piyush Sharma
CMP | Compliance Officer | - | 20/09/22 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Pyott
BRD | Director/Board Member | 70 | 17/12/15 |
Charles Sigal
BRD | Director/Board Member | 72 | 21/08/22 |
Margaret Hamburg
BRD | Director/Board Member | 68 | 09/01/19 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
5.08% | 1 M€ | +0.15% | - | |
4.04% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
16/05/24 | 148 | +0.42% | 466 297 |
15/05/24 | 147.4 | -0.33% | 536,143 |
14/05/24 | 147.9 | -1.33% | 604,966 |
13/05/24 | 149.9 | -0.39% | 512,792 |
10/05/24 | 150.5 | -0.59% | 322,795 |
Delayed Quote Nasdaq, May 16, 2024 at 07:38 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.68% | 18.64B | |
+33.25% | 49.46B | |
+1.72% | 42.58B | |
+49.11% | 42.49B | |
-4.22% | 29.09B | |
+11.57% | 26.61B | |
+8.13% | 13.16B | |
+29.65% | 12.55B | |
+24.33% | 12.1B | |
-4.39% | 11.98B |
- Stock Market
- Equities
- ALNY Stock